The pharmaceutical trade is bracing for essentially the most important enlargement of presidency regulation of drug costs in a long time regardless of success in watering down proposals from congressional Democrats that will have gone a lot additional.
The Home final week accredited a roughly $2 trillion social-spending and local weather invoice supported by President Biden that requires the federal government to barter costs for some older high-cost medicines coated by Medicare. The invoice additionally caps annual drug worth will increase on the charge of inflation. The measures scale back federal drug spending—and trade income—by $128 billion over 10 years, in line with the Congressional Price range Workplace.
